Our nontargeted discovery services allow for broad profiling of the tens of thousands small molecules in circulation, enabling rapid identification of known biomarkers and importantly, amplifying your ability to discover biologically relevant biomarkers that may not yet be known.
Sapient can also support studies that seek to analyze specific metabolites or lipids with our focused chemical panels. Benefit from the same rapid turnaround of data, analyses, and insights for the subset of biomarkers that interest you most.
We customize our discovery metabolomics and lipidomics services to your needs by understanding the details of the biological questions you want to answer and designing a project that provides you with the data you need, including for:
Evaluate the biological activity of a drug.
From rapid turnaround times to flexible engagement options, including pilot programs to kick-start discovery, we’re here to accelerate your R&D.